Vetter Pharma International GmbH


Vetter Pharma International GmbH

Established: ​1950

Number of staff: ​Approximately 5,700

Key Personnel: ​Thomas Otto, managing director; Peter Soelkner, managing director

Vetter is a global leading contract development and manufacturing organization (CDMO) headquartered in Ravensburg with production facilities in Germany, Austria and the US and an international specialist in the production of aseptically pre-filled syringe systems, cartridges and vials.

With years of experience and the dedication of our employees, we support companies from early process development through clinical and commercial filling to a wide variety of packaging solutions for vials, syringes and cartridges.

As a provider of innovative solutions, we have made it our mission to work with our clients to develop injection systems for the continuous improvement of patient safety, comfort and compliance. We are committed to the principles of sustainability and act as a corporate citizen in a socially and ethically responsible manner.

Services Offered

Vetter Development Service includes:

  • Process Development
  • Clinical Trial Manufacturing
  • Analytical Services
  • Regulatory Support

Vetter Commercial Manufacturing includes:​ 

  • Fill & Finish
  • Analytical Services
  • Regulatory Support
  • Life Cycle Management

Vetter Packaging Solutions include:

  • Customized Packaging Development
  • Systems & Technologies
  • Logistics Services
  • Serialization
  • Sterile Water for Injection

Dosage forms: ​Syringes, cartridges and vials 

Our customers represent the entire range of small to large companies in the pharmaceutical and biotechnological industries.

Related resources

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Vetter Pharma

Meeting the challenges of complex drug substances

Vetter Pharma International GmbH | 15-Apr-2014 | Technical / White Paper

Realizing the full potential of an injectable drug compound is no small task. In the months and years that lead from the discovery phase to the rigorous...

Vetter – Answers that work

Vetter – Answers that work

Vetter Pharma International GmbH | 03-Oct-2012 | Data Sheet

There are many sides to your product’s success. Build them together at Vetter.Whether your injectable is still at the starting line or in full-scale production, there...